Evaluating the Efficacy and Effectiveness of Long Acting Injectables Versus Oral Antipsychotics in the Treatment of Schizophrenia
Date: Jun 19, 2020 01:30 PM - 02:30 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Aug 14, 2020 11:55 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Evaluating the Efficacy and Effectiveness of Long Acting Injectables Versus Oral Antipsychotics in the Treatment of Schizophrenia
Registration Closed
Evaluating the Efficacy and Effectiveness of Long Acting Injectables Versus Oral Antipsychotics in the Treatment of Schizophrenia
Registration Closed
Objectives
- Describe the clinical manifestations of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM5)
- Explain the pharmacological treatment approach for schizophrenia and identify the differences in tolerability of typical and atypical antipsychotic
- Identify the clinical factors and patient preferences that influence the prescribing of different antipsychotic formulations
- Interpret the clinical trial outcomes of studies regarding the use of long acting injectables versus oral antipsychotics in schizophrenia therapy
Speaker(s)/Author(s)
|
Jessica Pinchinat, PharmD, RPh |
Activity Number
0010-0000-20-019-L01-P
Date:
06/19/20
Time:
01:30 PM - 02:30 PM
CE Hours
1.00
Registration Closed